Home › Funds › SECTOR GAMMA AS › BMRN

SECTOR GAMMA AS position in BMRN

BIOMARIN PHARMACEUTICAL INC · Health Care

SECTOR GAMMA AS reported holding 293,293 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$17.6M, representing 3.63% of its reported portfolio and ranking #6 among its reported holdings. SECTOR GAMMA AS has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)293.29K sh
Reported value held$17.60M
Portfolio Weight3.63%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SECTOR GAMMA AS's BMRN position evolved

SECTOR GAMMA AS first disclosed a stake in BMRN in Q3 2023 at 96,048 shares (US$8.5M). The position peaked in Q3 2026 at 293,293 shares, worth US$17.6M. Across 13 filings, SECTOR GAMMA AS increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 293,293 shares valued at US$17.6M — a reduction of -1,625 shares quarter over quarter.. Notable position changes include a 200% increase in Q3 2024 (shares fell 6% over the following quarter), a 37% trim in Q1 2025 (shares fell 22% over the following quarter), a 44% increase in Q3 2025 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 96.05K $8.50M New
Q4 2023 86.25K $8.32M Reduce
Q1 2024 81.42K $7.11M Reduce
Q2 2024 63.35K $5.22M Reduce
Q3 2024 190.35K $13.38M Add
Q4 2024 217.35K $14.29M Add
Q1 2025 137.35K $9.71M Reduce
Q2 2025 122.35K $6.73M Reduce
Q3 2025 175.85K $9.52M Add
Q4 2025 198.50K $11.80M Add
Q1 2026 239.92K $13.55M Add
Q2 2026 294.92K $16.88M Add
Q3 2026 293.29K $17.60M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BMRN and 13F data

BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BMRN

All BMRN fund holders →

FAQ

How long has SECTOR GAMMA AS held BMRN?

SECTOR GAMMA AS has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SECTOR GAMMA AS's current position in BMRN?

As of Q3 2026, SECTOR GAMMA AS holds 293.29K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $17.60M, representing 3.63% of its reported portfolio and ranking #6.

Has SECTOR GAMMA AS been buying or selling BMRN?

In the latest 13F filing (Q3 2026), SECTOR GAMMA AS reduced its position in BMRN. The position peaked in Q3 2026 at 293.29K shares.

Which other funds hold BMRN?

Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.